Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Warner

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Molecular Pharmacology|September 23, 2003
Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cellsMandy Woods, Elizabeth G Wood, Sonya C Bardswell, et al.
Biochemical and Biophysical Research Communications|June 17, 2006
The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cellsFrancisco Perez-Vizcaino, David Bishop-Bailley, Federica Lodi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2013
Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxideNicholas S Kirkby, Martina H Lundberg, Melissa V Chan, et al.
Thrombosis and Haemostasis|October 7, 2009
Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectivenessPaul C J Armstrong, Al-Rehan Dhanji, Nicola J Truss, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2017
Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet TherapiesPaul C Armstrong, Thomas Hoefer, Rebecca B Knowles, et al.
Blood Advances|August 29, 2022
Temporal in vivo platelet labeling in mice reveals age-dependent receptor expression and conservation of specific mRNAsPaul C Armstrong, Harriet E Allan, Nicholas S Kirkby, et al.
Biochemical and Biophysical Research Communications|July 16, 2013
Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapiesNicholas S Kirkby, Anne K Zaiss, William R Wright, et al.
American Journal of Physiology. Renal Physiology|June 6, 2008
Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivoErika I Boesen, Jennifer M Sasser, Mohamed A Saleh, et al.
Circulation Research|September 13, 2019
Cell-Specific Gene Deletion Reveals the Antithrombotic Function of COX1 and Explains the Vascular COX1/Prostacyclin ParadoxJane A Mitchell, Fisnik Shala, Youssef Elghazouli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2009
Antiplatelet actions of statins and fibrates are mediated by PPARsFerhana Y Ali, Paul C J Armstrong, Al-Rehan A Dhanji, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Molecular Pharmacology|September 23, 2003
Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cellsMandy Woods, Elizabeth G Wood, Sonya C Bardswell, et al.
Biochemical and Biophysical Research Communications|June 17, 2006
The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cellsFrancisco Perez-Vizcaino, David Bishop-Bailley, Federica Lodi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 5, 2013
Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxideNicholas S Kirkby, Martina H Lundberg, Melissa V Chan, et al.
Thrombosis and Haemostasis|October 7, 2009
Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectivenessPaul C J Armstrong, Al-Rehan Dhanji, Nicola J Truss, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 11, 2017
Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet TherapiesPaul C Armstrong, Thomas Hoefer, Rebecca B Knowles, et al.
Blood Advances|August 29, 2022
Temporal in vivo platelet labeling in mice reveals age-dependent receptor expression and conservation of specific mRNAsPaul C Armstrong, Harriet E Allan, Nicholas S Kirkby, et al.
Biochemical and Biophysical Research Communications|July 16, 2013
Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapiesNicholas S Kirkby, Anne K Zaiss, William R Wright, et al.
American Journal of Physiology. Renal Physiology|June 6, 2008
Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivoErika I Boesen, Jennifer M Sasser, Mohamed A Saleh, et al.
Circulation Research|September 13, 2019
Cell-Specific Gene Deletion Reveals the Antithrombotic Function of COX1 and Explains the Vascular COX1/Prostacyclin ParadoxJane A Mitchell, Fisnik Shala, Youssef Elghazouli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2009
Antiplatelet actions of statins and fibrates are mediated by PPARsFerhana Y Ali, Paul C J Armstrong, Al-Rehan A Dhanji, et al.
Pageof 12